The FDA will allow genetic testing company 23andMe to market personal genome reports as a direct-to-consumer test of a person’s ability to metabolize some medications to help inform discussions with healthcare providers.

A large chunk of the American population doesn’t know when the open enrollment period is to purchase healthcare insurance, according to a recent study by insuranceQuotes. And recent political moves have contributed to confusion among Americans.

Industry groups and healthcare experts disagree on various parts of President Trump's new plan to lower Medicare Part B drug prices, which was announced last week.

The FDA approved a new flu medicine that could shorten the time people are sick—and it can be taken in one dose.

More than 25 patient and consumer groups have spoken out against a new guidance issued by CMS on Tuesday that allows states to skirt patient protections mandated under the Affordable Care Act.

More than 100 million individuals would be impacted by rollbacks in protections for pre-existing conditions mandated under the Affordable Care Act, according to consulting firm Avalere Health.

As the state of New York considers the pending $69 billion merger between retail pharmacy chain CVS Health and health insurance giant Aetna, CVS’ practices in drug pricing are coming under the microscope.

While many GOP leaders have demonized a Medicare for all policy popularized by Sen. Bernie Sanders (I-VT), many Republicans are actually supportive of such a proposal, according to a recent poll by HillTV and the HarrisX polling company.

CMS and the Treasury Department have introduced new guidance on health insurance markets that will allow states to sell plans with looser restrictions.

A policy of denying emergency coverage by Anthem Blue Cross Blue Shield could leave nearly one in six patients vulnerable if it is adopted nationwide.

Industry groups have submitted their final comments on CMS’ recent proposal to overhaul the Medicare Shared Savings Program, warning that some of the new changes could result in fewer accountable care organizations participating in the program.

As Canada is set to legalize marijuana use on Oct. 17, Walmart—the world’s largest employer—is seriously considering adding cannabis products alongside other medications in its aisles in the country, according to Hemp Industry Daily.